Collegium Pharmaceutical
$37.19
11
-$0.43-1.14% Friday 20:00
Statistik
Harga Tertinggi Hari
38.16
Harga Terendah Hari
37.16
52M Tertinggi
40.95
52M Terendah
20.95
Volum
167,043
Volum Purata
469,761
Kapasiti Pasaran
1.24B
Nisbah P/E
14.46
Pendapatan Dividen
-
Dividen
-
Akan Datang
Pendapatan
6NovDijangka
EPS yang dijangka
1.5975
EPS sebenar
N/A
Orang Lain Juga Mengikuti
Senarai ini berdasarkan senarai pantau orang di Stock Events yang mengikuti COLL. Ini bukan cadangan pelaburan.
Peserta
Senarai ini adalah analisis berdasarkan peristiwa pasaran terkini. Ini bukan cadangan pelaburan.
Teva- Pharmaceutical Industries
TEVA
Kapasiti Pasaran21.38B
Johnson & Johnson
JNJ
Kapasiti Pasaran399.26B
Abbvie
ABBV
Kapasiti Pasaran346.75B
AMGEN
AMGN
Kapasiti Pasaran179.38B
Merck
MRK
Kapasiti Pasaran300.25B
Pfizer
PFE
Kapasiti Pasaran164.39B
Pacira BioSciences
PCRX
Kapasiti Pasaran717.73M
Penilaian Penganalisis
43.25$Sasaran Harga Purata
Anggaran tertinggi adalah $50.
Dari 5 penilaian dalam tempoh 6 bulan terakhir. Ini bukan cadangan pelaburan.
Beli
60%
Pegang
40%
Jual
0%
Mengenai
Health Technology
Pharmaceuticals: Other
Manufacturing
Pharmaceutical Preparation Manufacturing
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
Show more...
CEO
Joseph Ciaffoni
Pekerja
197
Negara
US
ISIN
US19459J1043